GL1X · GenesisL1 explorer

MolNFT v1 · #93337 · protein

Multi-drug resistant HIV-1 protease 769 variant with reduced lrf peptide

4GZF: “Multi-drug resistant HIV-1 protease 769 variant with reduced lrf peptide”. X-ray diffraction, 1 ligand (DC0), 1 pocket (best druggability 0.66). MolNFT v1 #93337 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4GZF
Type
protein
Length
203 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease; Lrf peptide
EC
3.4.23.16
UniProt
Q9QM22
Ligands
DC0
Pockets
1 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 4% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein994% helix, 53% strandQ9QM22
CLrf peptideprotein50% helix, 20% strand—

Ligands and binding sites

  • DC0 · N-[(2S)-2-amino-4-methylpentyl]-L-phenylalanine · ligand · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11590.660.8734DC0

Interfaces

3 interfaces between chains.

  • A–B · 1863 Ų buried · 38 hydrogen bonds · protein-protein
  • A–C · 355 Ų buried · 12 hydrogen bonds · protein-protein
  • B–C · 338 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 modified (covalent ligand, nonstandard).

Compared structures

  • 4GZF · Multi-drug resistant HIV-1 protease 769 variant with reduced LrF peptide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.